# US 8,278,356 B2 · Phloroglucinol derivatives having selectin ligand activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,356 B2
- Document ID: US8278356B2
- Status: Granted
- Kind: B2
- Application number: 13/032,760
- Filed: 2011-02-23
- Published: 2011-06-16
- Granted: 2012-10-02
- Earliest claimed: 2005-09-20
- Assignees: Revotar Biopharmaceuticals AG
- Inventors: Ewald Aydt; Remo Kranich
- Web page: https://patentgrep.com/patent/US8278356B2

## Abstract

Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning —X— is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or selectin binding.

## Claims

### Claim 1

A compound of the formula (I):
wherein the symbols and substituents have the following meaning:
—X—Y is
with m=0 or 1; n=an integer from 1 to 3;
—Y is
in which s is 0 or 1;
R2 is CO2H, CO2alkyl, CO2aryl, CO2NH2, CO2aralkyl, CH2SO3H, CH2SO2NH2, CH2PO2(OH)2, SO3H, SO2NH2, PO(OH)2, 1-H-tetrazolyl-, CHO, COCH3, CH2OH, CH2NH2, NH2, CH2NHalkyl, CH2N(alkyl)alkyl′, NHalkyl, N(alkyl)alkyl′, OCH3, CH2OCH3, CH2SH, SH, F, Cl, Br, I, CH3, CH2CH3, CN, or CF3;
R3 independently from R2 is H, CH3, CH2CH3, CF3, F, Cl, Br, I, CN, or NO2;
R4 independently from R2 and R3 is H, CH3, CH2CH3, CF3, F, Cl, Br, I, CN, NO2, or R2;
R5 is H, NO2, CF3, F, Cl, Br, I, CN, CH3, OCH3, SH, or NH2;
—W— is —(CH2—)v, cis-CH═CH— or trans-CH═CH—, and v is 0, 1, or 2;
in case that —W— is cis-CH═CH— or trans-CH═CH—, R2 must not be NH2 or SH;
R6 independently from R2 is H, F, Cl, Me, tert-Bu, CN, or NH2;
in which t is 0, 1, or 2;
—Z is
R7 independently from R2 is H, NO2, CF3, F, Cl, Br, I, CN, CH3, OCH3, SH, or NH2;
in which K is NH, NMe, O, or S;
or a pharmaceutically acceptable salt, ester, or amide thereof or a prodrug thereof of the above identified compounds of formula (I).

### Claim 2 (depends on 1)

The compound of claim 1 defined by formulas (A) or (B)
wherein —X—Y′ is
with m=0 or 1: n=an integer from 1 to 3;
and wherein —Y′ is
and wherein —X″—Y is
with m=0; n=an integer from 1 to 2;
and wherein —Y is as defined in claim 1;
and wherein all other indices, symbols, and substituents are as defined in claim 1.

### Claim 3 (depends on 1)

The compound of claim 1 defined by formula (C):
wherein —X″—Y′ is
with m=0; n=an integer from 1 to 2;
and wherein —Y′ is
wherein all other indices, symbols, and substituents are as defined in claim 1.

### Claim 4 (depends on 1)

The compound of claim 1 defined by formula (D):
wherein —X″—Y″ is
with m=0; n=an integer from 1 to 2;
and wherein —Y″ is
wherein R9 is CO2H, CO2alkyl, CO2aryl, CO2NH2, CO2aralkyl, CH2SO3H, CH2SO2NH2, CH2PO2(OH)2, 1-H-tetrazolyl-, CHO, COCH3, CH2OH, CH2NH2, CH2NHalkyl, CH2N(alkyl)alkyl′, CH2OCH3, or CH2SH,
wherein all other indices, symbols, and substituents are as defined in claim 1.

### Claim 5 (depends on 1)

A cosmetic or dermatological composition, comprising at least one compound of claim 1.

### Claim 6 (depends on 1)

A cosmetic composition comprising at least one compound of claim 1 and at least one cosmetically tolerable component.

### Claim 7 (depends on 1)

A dermatological composition comprising at least one compound of claim 1 and at least one dermatologically tolerable component.

### Claim 8 (depends on 1)

A pharmaceutical composition comprising at least one compound of claim 1 and a pharmaceutically acceptable excipient.

### Claim 9 (depends on 2)

A pharmaceutical composition comprising at least one compound of claim 2 and a pharmaceutically acceptable excipient.

### Claim 10 (depends on 3)

A pharmaceutical composition comprising at least one compound of claim 3 and a pharmaceutically acceptable excipient.

### Claim 11 (depends on 4)

A pharmaceutical composition comprising at least one chemical compound of claim 4 and a pharmaceutically acceptable excipient.
